The safety and efficacy of recombinant neuregulin-1 (rhNRG-1) in patients with stable chronic heart failure

Trial Profile

The safety and efficacy of recombinant neuregulin-1 (rhNRG-1) in patients with stable chronic heart failure

Recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2016

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top